Stock DNA
Pharmaceuticals & Biotechnology
INR 439 Cr (Micro Cap)
15.00
40
0.66%
0.00
0.00%
1.02
Total Returns (Price + Dividend) 
Latest dividend: 5 per share ex-dividend date: Jul-30-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Albert David Ltd Valuation Shifts Signal Attractive Entry Point Amid Sector Challenges
Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift favourably, prompting an upgrade in its investment grade from Hold to Buy. With a current price of ₹778.90 and a price-to-earnings (P/E) ratio of 15.46, the stock now presents an attractive valuation compared to its historical averages and peer group, signalling a potential opportunity for investors seeking value in a competitive industry.
Read More
Albert David Ltd is Rated Hold by MarketsMOJO
Albert David Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 07 October 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 11 November 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Albert David Ltd Valuation Shifts to Attractive Amid Sector Challenges
Albert David Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. This change comes amid a backdrop of mixed returns and sector-wide valuation pressures, prompting investors to reassess the stock’s price attractiveness relative to its peers and historical benchmarks.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
18-Nov-2026 | Source : BSENewspaper publication dated 18th November 2026 in Financial Express(All India Editions) and Aajkal (Bengali Newspaper) about 5th Reminder for Special Window for Re-lodgment of physical Transfer
Announcement under Regulation 30 (LODR)-Newspaper Publication
13-Nov-2026 | Source : BSENewspaper Publication-Regarding Extract of Unaudited Financial Results for the quarter and half year ended 30th September 2026
Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2026
12-Nov-2026 | Source : BSEUnaudited Financial Results for the quarter and half year ended 30th September 2026
Corporate Actions 
No Upcoming Board Meetings
Albert David Ltd has declared 50% dividend, ex-date: 30 Jul 26
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 5 FIIs (0.6%)
Kothari Investment And Industries Private Limited (41.36%)
General Insurance Corporation Of India (1.61%)
27.92%
Quarterly Results Snapshot (Standalone) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is 15.58% vs -11.38% in Sep 2025
YoY Growth in quarter ended Sep 2026 is 187.27% vs -118.26% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -15.96% vs 1.44% in Sep 2024
Growth in half year ended Sep 2025 is -87.43% vs -15.69% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -8.54% vs -0.93% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -27.57% vs -55.96% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is -3.52% vs -4.60% in Mar 2025
YoY Growth in year ended Mar 2026 is -108.66% vs -77.19% in Mar 2025